Portfolio
Akeso is a medical technology company (Philips spin-out), developing an imaging apparatus to measure and monitor rheumatoid arthritis disease activity in the joints of the hands.
arGEN-X is monoclonal antibody company employing proprietory superior therapeutic antibody discovery platform to develop own antibody product portfolio.
Avantium is a Dutch service and R&D company. Avantium provides innovative high-throughput R&D services and technologies to the pharmaceutical, chemical and energy industries.
Bioceros is active in the field of protein therapeutics, and offers producer cell line generation services; it also aims to develop an own therapeutic monoclonal antibody pipeline.
BioXell was a research and development biopharmaceutical company with globally recognised leadership in Vitamin D and its in-depth understanding of the molecular basis of inflammation. The company was acquired by Cosmo Pharmaceuticals.
Breonics, Inc. is a biomedical research and development company on the cutting edge of innovative medical products for the clinical organ transplant and tissue replacement markets.
Cavadis is a biomarker company aiming to develop in vitro diagnostics for cardiovascular risk assessment.
Coley Pharmaceutical Group discovers, develops and commercializes a new class of drugs that stimulate the human immune system to treat and prevent cancer, asthma, allergy and infectious diseases. The company was acquired by Pfizer.
Curacyte is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care.
DCPrime is a biotech company with a proprietary allogeneic dendritic cell line as a platform to derive and develop the next generation therapeutic dendritic cancer vaccines.
DeveloGen is a biology driven specialty pharmaceutical company focusing on the development of treatments for metabolic disorders, such as diabetes, obesity and metabolic syndrome. The company was acquired by Evotec.
DrugAbuse Sciences was a specialty pharmaceutical company dedicated to improving the treatment of alcohol and substance abuse and dependence. The company assets have been acquired by Elbion.
Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best-in-class small molecule drugs in the anti-infectives field.
EpiCept Corporation is a specialty niche pharmaceutical company. Epicept’s objective is to address unmet medical needs in cancer and pain management. The company is listed on the OTCQX and Stockholm Stock Exchange.
Fabpulous develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability (lateral flow). The first application is a rapid h-FAPB test as an aid in the early diagnosis of a heart infarct.
Galapagos is a biotechnology company focused on the identification of disease modifying drug targets and the subsequent development of breakthrough medicine based on these targets. The company is listed on Euronext.
Ingenium Pharmaceuticals is a drug discovery and development company focused on generating the biological information critical to the development of therapeutics, specifically in the area of pain management and inflammatory disease. The company was acquired by ProBiodrug AG.
Intercell is a biotechnology company focused on the development of vaccines against infectious diseases and cancer, listed on the Vienna Stock Exchange.
NightBalance is a medtech company developing and commercializing a patient-friendly device to treat positional sleep apnea.
Okapi develops antiviral drug products to treat viral diseases in pet animals and livestock.
OMRIX biopharmaceuticals is a marketing stage biotechnology company that develops and markets a unique surgical sealant, as well as a suite of immunology and hemophilia products. The company was acquired by J&J.
TheraSolve develops a skin patch technology (embedded electronics) to improve drug treatment compliance.
Vernalis is a development-stage pharmaceutical company listed on the London Stock Exchange.